In a decision that could damage the quality of retirement living for many seniors, the U.S. Senate recently voted against lowering prescription drug prices.
On December 15, the Senate rejected an amendment to the Patient Protection and Affordable Care Act that would have made prescription drugs cheaper by letting medications from abroad be sold in the U.S.
The amendment, which was endorsed by the AARP, might have lowered drug costs by creating competition among manufacturers.
"AARP is also deeply disappointed that Senator Casey voted today for continuing the status quo and against lower prescription drug prices for his constituents," said Dick Chevrefils, AARP Pennsylvania state director, of the Pennsylvanian junior senator. "With brand name drug prices rising at alarming rates, we hope he will further review the negative impact on the people of Pennsylvania and reconsider his position."
AARP, which has long been trying to reduce the price of medication, was founded in 1958, according to the association's website. The organization now has 40 million members and offices in every U.S. state.